Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
365.00    20.00 (5.80%)
Bid:
350.00
Ask:
380.00
Spread: 30.00 (8.571%)
Market Cap: £34.88m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Directorate Changes

22 Jul 2024 09:43

RNS Number : 2809X
Cropper(James) PLC
22 July 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE UK'S MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, SUCH INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

22 July 2024

 

 

James Cropper plc

('James Cropper', the 'Company' or the 'Group')

 

Directorate Changes

 

James Cropper plc (AIM: CRPR), the Advanced Materials and Paper & Packaging group, announces that Jon Yeung will be appointed as an independent Non-Executive Director and join the Board following conclusion of the Company's AGM expected to take place in September 2024 ("AGM").

 

Jon is a chartered accountant and brings significant experience in creating shareholder value through long-term business transformation and growth. During 11 years at LGC Science Group - a global life sciences group serving a variety of end markets globally - Jon held various leadership roles, including Group Finance Director and COO/Managing Director of the £400m Standards division, during which the business saw significant growth. Prior to this Jon spent 16 years at PricewaterhouseCoopers LLP working extensively with listed businesses across audit and transaction projects including financing and M&A. Jon is currently a Non-Executive Director and Audit Committee Chair at private equity owned Fera Science. He also serves as an advisory Board member for Charterpath, a not-for-profit organisation which seeks to connect individuals with finance skills with charities.

 

Upon joining the Board, Jon will be appointed as Audit Committee Chair and will serve as a member of the Remuneration and Nomination Committees.

 

The Board also announces that Jim Sharp will stand down as a Non-Executive Director and from the Board upon conclusion of the Company's forthcoming AGM after 15 years' service.

 

Further information relating to Jon Yeung in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies is set out at the end of this announcement.

 

Mark Cropper, Non-Executive Chair, commented:

 

"On behalf of the Board, I am delighted to welcome Jon to James Cropper. Jon's depth of finance, leadership and business growth experience will be hugely beneficial to the Board as we seek breakout growth in the coming years, and I look forward to working with him.

 

"I would also like to thank Jim for his unwavering support and commitment to James Cropper over the last 15 years. Jim has made a very significant contribution during his tenure, and he steps down from the Board with our sincerest gratitude."

 

 

-ENDS-

 

Enquiries:

 

James Cropper plc Mark Cropper, Non-Executive Chair

+44(0)1539 722002

 

Shore Capital - (Nominated Adviser and Broker)

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

Tel: +44 (0)207 408 4090

 

Burson Buchanan - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

Regulatory Disclosures:

 

Save for the information set out herein, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Jonathan Mark Yeung (aged 51).

 

Current Directorships and Partnerships

Cricket Dorset Limited

Fera Science Limited

Hazel II Topco Limited

LGC Science and Standards (India) Private Limited

 

Past Directorships and Partnerships

9123725 Canada Inc.

Innovaspeak Limited

M.B.H. Analytical Limited

Paragon Scientific Limited

Techno-Path Manufacturing Limited

 

Notes for editors:

 

James Cropper is a market leader in Advanced Materials and Paper & Packaging, centred around four market audiences: Energy Solutions, Composite Solutions, Luxury Packaging and Creative Papers.

 

A purpose-led business, built upon six generations of the Cropper family, James Cropper has a 600+ international workforce and an operational reach in over 50 countries.

 

Established in 1845, the Group manufactures creative papers, luxury packaging and advanced materials incorporating pioneering non-wovens and electrochemical coatings.

 

James Cropper is a specialist provider of niche solutions tailored to a unique customer specification, ranging from substrates and components in hydrogen electrolysis and fuel cells to bespoke colours and textures in paper and moulded fibre packaging designed to replace single use plastics.

 

The Group operates across multiple markets from luxury retail to renewable energy. It is renowned globally for service, capability, pioneering and multi award-winning commitment to the highest standards of sustainability.

 

James Cropper's goal is to be operationally net zero by 2030 and to reduce carbon through its entire supply chain to net zero by 2050.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUPCMUPCURP
Date   Source Headline
18th Jul 20164:13 pmRNSDirector/PDMR Shareholding
28th Jun 20167:00 amRNSFinal Results
13th Jun 20162:54 pmRNSHolding(s) in Company
3rd May 20165:07 pmRNSHolding(s) in Company
13th Apr 20163:25 pmRNSIssue of Equity
11th Apr 20163:39 pmRNSHolding(s) in Company
11th Apr 20167:00 amRNSTrading Update
31st Mar 20161:09 pmRNSDirector/PDMR Shareholding
20th Jan 20164:57 pmRNSDirector/PDMR Shareholding
19th Jan 20161:24 pmRNSDirector Dealing
7th Jan 20167:00 amRNSChange of name of Nominated Adviser and Broker
23rd Dec 20157:00 amRNSIssue of Equity
16th Dec 20158:35 amRNSIssue of Equity
16th Dec 20157:00 amRNSDirector Dealing
15th Dec 20158:58 amRNSUpdate re Storm Desmond
8th Dec 20157:00 amRNSImpact of Storm Desmond
1st Dec 20154:59 pmRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSIssue of Equity
24th Nov 20152:55 pmRNSDirector/PDMR Shareholding
24th Nov 20157:00 amRNSIssue of Equity
16th Nov 201510:36 amRNSDirectors' Dealings and LTIP Award
10th Nov 20157:00 amRNSHalf Yearly Report
18th Sep 20153:04 pmRNSDirector/PDMR Shareholding
7th Sep 20152:25 pmRNSDirectors' Interests
21st Aug 20157:00 amRNSDirectors' Dealings and LTIP Award
4th Aug 20159:37 amRNSDirector/PDMR Shareholding
4th Aug 20157:01 amRNSHolding(s) in Company
3rd Aug 201511:48 amRNSDirectors' option interests
31st Jul 20154:35 pmRNSHolding(s) in Company
29th Jul 201511:00 amRNSAGM and Trading Update
28th Jul 20158:55 amRNSDirectors' interests
16th Jul 20158:24 amRNSDirector/PDMR Shareholding
14th Jul 20158:33 amRNSDirector Dealing
8th Jul 20154:42 pmRNSDirector/PDMR Shareholding
24th Jun 20157:00 amRNSFinal Dividend - ex-date correction
23rd Jun 20157:00 amRNSFinal Results
1st Jun 20159:16 amRNSDirectors' interests
19th May 20154:25 pmRNSDirector/PDMR Shareholding
8th May 20157:00 amRNSIssue of Equity
29th Apr 20157:00 amRNSIssue of Equity
31st Mar 201512:44 pmRNSDirectors' option interests
9th Mar 20152:31 pmRNSReplacement - Director/PDMR Shareholding
6th Feb 201510:28 amRNSDirector Shareholding
13th Jan 20159:46 amRNSHolding(s) in Company
8th Dec 20147:00 amRNSDirector/PDMR Shareholding
3rd Dec 20147:00 amRNSIssue of Equity
19th Nov 20144:23 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSIssue of equity and director dealings
11th Nov 20147:00 amRNSHalf-year results to 27 September 2014
22nd Sep 20142:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.